Literature DB >> 6427462

Circulating thiomalate after administration of disodium aurothiomalate: impurity or active metabolite?

S R Rudge, D Perrett, A J Swannell, P L Drury.   

Abstract

During studies of the metabolism of disodium aurothiomalate in patients with rheumatoid arthritis we have found that its pharmaceutical preparation. Myocrisin, contains 4 to 8% of free thiomalate. To establish whether the free thiomalate previously reported in plasma and urine of patients receiving Myocrisin is a true metabolite or results from this impurity, we prepared aurothiomalate containing 0.1% thiomalate. Intramuscular injection of the purified drug to 2 healthy subjects produced easily detectable levels of thiomalate in both plasma and urine; 7.7 and 9.8% respectively of the doses given were recovered in urine as free thomalate within 4 h. Thus, dissociation of disodium aurothiomalate does occur in vivo, releasing both gold and free thiomalate as potentially active forms.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6427462

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Binding of sodium aurothiomalate to human serum albumin in vitro at physiological conditions.

Authors:  S M Pedersen
Journal:  Ann Rheum Dis       Date:  1986-09       Impact factor: 19.103

2.  Failure of oral thiomalate to act as an alternative to intramuscular gold in rheumatoid arthritis.

Authors:  S R Rudge; D Perrett; M Kelly
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

3.  Progress in the characterization of gold drugs.

Authors:  M C Grootveld; M T Razi; P J Sadler
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

4.  Free thiomalate levels in patients with rheumatoid arthritis treated with disodium aurothiomalate: relationship to clinical outcome of therapy.

Authors:  S R Rudge; D Perrett; A J Swannell
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103

5.  Effect of gold sodium thiomalate and its thiomalate component on the in vitro expression of endothelial cell adhesion molecules.

Authors:  P M Newman; S S To; B G Robinson; V J Hyland; L Schrieber
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.